At least three provinces Ontario, Quebec and Manitoba have each reported an increased number of calls involving semaglutide, Ozempics generic name, to its poison control centres this year, with each seeing more than a 50-per-cent increase compared to 2022, though the numbers do not specify if the calls are from diabetes users or those taking it for weight loss
This trial led the FDA to expand Wegovy's label to include reducing cardiovascular risk in people with obesity
Q9: What are the side effects of semaglutide
Vitamin B6 and risk of colorectal cancer
While Ozempic and other GLP-1 medications are primarily used to manage type 2 diabetes, they have been associated with severe digestive issues such as gastroparesis, a condition that delays stomach emptying, leading to chronic nausea, vomiting, and malnutrition
Patients should discuss regulatory status and legal access with their physician before starting